Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Features of patients treated with nilotinib as first-line treatment tested for TTV load.
| Feature | Number (%) |
|---|---|
| Total patients number (nilotinib) | 10 |
| Sex | |
| Male | 6 (60%) |
| Female | 4 (40%) |
| Age, median (range) | 46 (27–63) |
| Sokal Risk | |
| Low | 3 (30%) |
| Intermediate | 6 (60%) |
| High | 1 (10%) |
| EMR (BCR-ABL1/ABL1 ≤ 10% at 3 months) | 9 (90%) |
| CCyR (no Philadelphia) at 6 months | 9 (90%) |
| MR3 at 12 months (BCR-ABL1/ABL1 ≤ 0.1%) | 9 (90%) |
